Interestingly, LSM8 (i.e. NAA38) was found to be one of the top driver oncogenes in patients with breast cancer (BC)41, whereas, it is already known that BC is more prevalent among patients with thyroid disorders42. This evidence concerns the gene LSM8 and breast carcinoma.